The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemoselection with induction chemotherapy followed by chemoradiation or surgery versus chemoradiation for patients (pts) with locally advanced squamous cell carcinoma of the oropharynx (LASCCOP).
I. Y. Dobrosotskaya
No relevant relationships to disclose
E. Light
No relevant relationships to disclose
J. M. Maxwell
No relevant relationships to disclose
S. A. Byrd
No relevant relationships to disclose
M. E. Spector
No relevant relationships to disclose
B. Kumar
No relevant relationships to disclose
F. Y. Feng
No relevant relationships to disclose
A. Eisbruch
No relevant relationships to disclose
G. T. Wolf
No relevant relationships to disclose
M. Prince
No relevant relationships to disclose
J. Moyer
No relevant relationships to disclose
T. N. Teknos
No relevant relationships to disclose
D. B. Chepeha
No relevant relationships to disclose
H. M. Walline
No relevant relationships to disclose
J. B. McHugh
No relevant relationships to disclose
K. G. Cordell
No relevant relationships to disclose
S. Urba
No relevant relationships to disclose
C. R. Bradford
No relevant relationships to disclose
T. Carey
No relevant relationships to disclose
F. P. Worden
No relevant relationships to disclose